EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Joint Impact of METS‐VF and Functional Limitation on Cardiometabolic Multimorbidity Risk

Xuhui Chen iD, Ying Wang, Jiaofen Wu, Yulian He, Huihui Chen iD, Honghua Ye, Jianhui Liu iD

Journal of Diabetes Research · 2026

DOI: 10.1155/jdr/6450867 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, 2026. Verfasst von Xuhui Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China, nbws.gov.cn. Hauptthemen laut MEDLINE: Activities of Daily Living, Intra-Abdominal Fat, Metabolic Syndrome, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ningbo Key Research and Development Program, Medical and Health Research Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiometabolic multimorbidity (CMM) has emerged as a primary public health challenge, significantly increasing mortality risk and reducing quality of life. Although the metabolic score for visceral fat (METS‐VF) and functional limitation are recognized individually as risk factors for cardiometabolic health, the bidirectional relationship between functional limitation and CMM suggests complex underlying mechanisms. However, research investigating the independent and joint effects of METS‐VF (representing visceral obesity) and functional limitation on the risk of CMM onset is lacking. This study is aimed at systematically elucidating these associations to provide evidence for targeted interventions.

Methods

This prospective cohort study utilized data from the China Health and Retirement Longitudinal Study (CHARLS). A total of 8140 participants were included in the cross‐sectional analysis, and a sub‐cohort of 5356 individuals free of CMM at baseline was followed longitudinally. CMM was defined as the coexistence of at least two cardiometabolic diseases: heart disease, diabetes, stroke, or hypertension. Functional limitation was assessed using activities of daily living (ADL) and instrumental ADL (IADL) scales. Multivariable Cox proportional hazards regression and restricted cubic spline (RCS) analysis were employed to evaluate the association between METS‐VF, functional limitations, and CMM incidence.

Results

During the follow‐up period, METS‐VF demonstrated a nonlinear positive dose‐response relationship with CMM risk. In the longitudinal analysis, participants in the high METS‐VF group (defined by the RCS inflection point) exhibited a significantly elevated risk of developing CMM compared to the low‐risk group (HR = 1.77, 95% CI: 1.39–2.26) after adjusting for confounders. Continuous functional limitations were also independently associated with incident CMM (HR = 1.12, 95% CI: 1.08–1.16). Notably, a joint effect was observed; participants with both high METS‐VF and functional limitations faced the highest risk (HR = 2.43, 95% CI: 1.78–3.31). Receiver operating characteristic (ROC) analysis indicated that the combined model incorporating both factors achieved superior predictive accuracy (AUC = 0.680) compared to single‐factor models.

Conclusion

METS‐VF and functional limitations are strong independent predictors of CMM, and their simultaneous presence exerts a significant joint effect on disease risk. The integration of METS‐VF and functional assessment into clinical practice can enhance CMM risk stratification and facilitate the early identification of vulnerable high‐risk subgroups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Activities of Daily LivingIntra-Abdominal FatMetabolic SyndromeCardiovascular DiseasesObesity, AbdominalHumansFemaleMaleMiddle AgedProspective StudiesAgedMultimorbidityChinaCross-Sectional StudiesLongitudinal StudiesRisk FactorsCardiometabolic Risk FactorsIncidenceDiabetes MellitusHypertension

Stichwörter der Autor:innen

CHARLScardiometabolic multimorbiditycohort studyfunctional limitationmetabolic score for visceral fat (METS-VF)visceral obesity

Autor:innen und Institutionen

  • Department of Pharmacy, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China, nbws.gov.cn.
  • Department of Cardiology, Ningbo Medical Center Lihuili Hospital, Ningbo, Zhejiang, China, nbws.gov.cn.

ORCID-Profile: Xuhui Chen, Huihui Chen, Jianhui Liu

Förderung

  • Ningbo Key Research and Development Program
  • Medical and Health Research Project of Zhejiang Province

Zitieren

APA

Chen, X., Wang, Y., Wu, J., He, Y., Chen, H., Ye, H., & Liu, J. (2026). Exploring the Joint Impact of METS‐VF and Functional Limitation on Cardiometabolic Multimorbidity Risk. Journal of Diabetes Research. https://doi.org/10.1155/jdr/6450867

Vancouver

Chen X, Wang Y, Wu J, He Y, Chen H, Ye H, et al. Exploring the Joint Impact of METS‐VF and Functional Limitation on Cardiometabolic Multimorbidity Risk. Journal of Diabetes Research. 2026. doi:10.1155/jdr/6450867

BibTeX
@article{Chen2026,
  author = {Chen, Xuhui and Wang, Ying and Wu, Jiaofen and He, Yulian and Chen, Huihui and Ye, Honghua and Liu, Jianhui},
  title = {Exploring the Joint Impact of METS‐VF and Functional Limitation on Cardiometabolic Multimorbidity Risk},
  journal = {Journal of Diabetes Research},
  year = {2026},
  doi = {10.1155/jdr/6450867}
}
Kostenlos starten →